These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22926613)

  • 41. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.
    Berwaerts J; Cleton A; Rossenu S; Talluri K; Remmerie B; Janssens L; Boom S; Kramer M; Eerdekens M
    J Psychopharmacol; 2010 Jul; 24(7):1011-8. PubMed ID: 19825908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania.
    Canuso CM; Battisti WP
    Expert Opin Pharmacother; 2010 Oct; 11(15):2557-67. PubMed ID: 20854185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Medication-related oculogyric crises: a description of four cases and a review of the literature].
    Darling A; Poo P; Perez-Duenas B; Campistol J
    Rev Neurol; 2013 Feb; 56(3):152-6. PubMed ID: 23359076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paliperidone-induced mania-like symptoms: a case report.
    Wang WT; Chen CH; Lu ML; Lai TJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1351-2. PubMed ID: 20600461
    [No Abstract]   [Full Text] [Related]  

  • 46. ECT, emergent dyskinesia, and depression.
    Flaherty JA; Naidu J; Dysken M
    Am J Psychiatry; 1984 Jun; 141(6):808-9. PubMed ID: 6145361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone and withdrawal dyskinesia.
    Lore C
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941. PubMed ID: 10939219
    [No Abstract]   [Full Text] [Related]  

  • 48. Tardive dyskinesia clinic.
    Achimovich LM
    Aust N Z J Psychiatry; 1989 Mar; 23(1):15. PubMed ID: 2564769
    [No Abstract]   [Full Text] [Related]  

  • 49. Risperidone/paliperidone induced neutropenia and lymphopenia.
    Raj V; Druitt T; Purushothaman S; Dunsdon J
    Aust N Z J Psychiatry; 2013 Mar; 47(3):291-2. PubMed ID: 22984110
    [No Abstract]   [Full Text] [Related]  

  • 50. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
    Canuso CM; Youssef EA; Bossie CA; Turkoz I; Schreiner A; Simpson GM
    Int Clin Psychopharmacol; 2008 Jul; 23(4):209-15. PubMed ID: 18545059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paliperidone-induced neuroleptic malignant syndrome.
    Nayak RB; Bhogale GS; Patil NM; Chate SS; Pandurangi AA; Shetageri VN
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E14-5. PubMed ID: 21304113
    [No Abstract]   [Full Text] [Related]  

  • 52. Tardive dyskinesia.
    Murray JB
    Genet Psychol Monogr; 1980 Nov; 102(2):161-90. PubMed ID: 6110612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Manic symptoms induced by paliperidone.
    Hsieh CH; Liou YJ
    J Clin Psychopharmacol; 2010 Apr; 30(2):202-4. PubMed ID: 20520298
    [No Abstract]   [Full Text] [Related]  

  • 54. Neuroleptic discontinuation syndromes.
    Tranter R; Healy D
    J Psychopharmacol; 1998; 12(4):401-6. PubMed ID: 10065916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
    Hough DW; Gopal S; Coppola D; Remmerie BM; Berwaerts J; Nuamah IF; Sterkens PC; Xu Y
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):298-9. PubMed ID: 22410947
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe depression with risperidone-induced EPS in an elderly schizoaffective patient.
    Benazzi F
    Can J Psychiatry; 1996 Apr; 41(3):196-7. PubMed ID: 8722655
    [No Abstract]   [Full Text] [Related]  

  • 58. Risperidone in adolescents.
    Cozza SJ; Edison DL
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
    [No Abstract]   [Full Text] [Related]  

  • 59. [Withdrawal symptoms of neuroleptics?].
    Mager T
    Med Monatsschr Pharm; 1994 Aug; 17(8):252. PubMed ID: 7935155
    [No Abstract]   [Full Text] [Related]  

  • 60. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.